Clinical Trial

Autologous Dendritic Cell Vaccine For Recurrent Respiratory Papillomatosis (RRP) Patients

Name: Autologous Dendritic Cell Vaccine For Recurrent Respiratory Papillomatosis (RRP) Patients — clinical trial record (NCT07317154)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The purpose of this study is to evaluate the safety and immunogenicity of autologous DC vaccine in recurrent respiratory papillomatosis patients

Protocol Amendment History 2 changes

notable Primary completion pushed: 2026-11 -> 2027-06 2026-07-11

minor Completion pushed: 2027-02 -> 2027-12 2026-07-11

Trial Details

NCT Number	NCT07317154
Lead Sponsor	Mayo Clinic
Conditions	Recurrent Respiratory Papillomatosis
Enrollment	9 participants
Start Date	2026-09
Primary Completion	2027-06 (estimated)
Study Completion	2027-12 (estimated)
Updated on ClinicalTrials.gov	2026-07-10